Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Observational × pembrolizumab × Clear all

Status

Completed 16 Unknown 14 Recruiting 11 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 267 Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Blood Specimen Collection 22 Surveys and Questionnaires 20 Magnetic Resonance Spectroscopy 9 Flow Cytometry 6 exemestane 5 Observation 5 Magnetic Resonance Imaging 5 Amplified Fragment Length Polymorphism Analysis 5 Specimen Handling 4 Radiotherapy 4 Radiation 4 Electroporation 4 Data Collection 4 Biopsy 4 Tomography, Optical Coherence 3 Therapeutics 3 Surgical Procedures, Operative 3 Registries 3 Radiosurgery 3 Paclitaxel 3 Neoadjuvant Therapy 3 Mental Status and Dementia Tests 3 Immunoenzyme Techniques 3 Genetic Testing 3 Gene Expression Profiling 3 Cetuximab 3 Bevacizumab 3 Watchful Waiting 2 Vinorelbine 2 Urine Specimen Collection 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04557007 2026-01-29

Oncomabs

Oslo University Hospital

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡